Ronald Li, PhD

Chairman, Chief Executive Officer, and Founder

Dr. Ronald Li has served as Chairman and CEO of Medera since September 2020. He is the founder of Medera and its underlying businesses. Dr. Li is an academic-turned-serial entrepreneur with successful track records in biotech from foundational to translational research, fundraising, public listing, mergers and acquisitions, privatization, joint ventures, licensing, and corporate finance. Dr. Li is an internationally recognized expert in cardiac electrophysiology, human heart cell and tissue engineering and pluripotent stem cells with over 200 peer-reviewed publications. Prior to founding Medera, Dr. Li was Assistant Professor at John Hopkins University, Associate Professor of University of California, Davis, Full Professor at Icahn School of Medicine at Mount Sinai in Manhattan, and Center Director of Ming-Wai Lau Center for Reparative Medicine at the Karolinska Institutet.

Dr. Li has won numerous awards and accolades, including being a two-time recipient of the Top Young Faculty Award of Johns Hopkins, Top Young Investigator and Top Postdoc Fellow of Johns Hopkins, Young Investigator Award 1st Prize of Heart Rhythm Society, American Heart Association Best Study of 2005 and Groundbreaking Study of 2006 for his work on the first genetically engineered human pluripotent stem cell-derived heart cells as well as cell- and gene-based biopacemakers. He has also been named a Distinguished Visiting Professor by the University of Toronto and Distinguished Alumnus by the University of Waterloo.